The Robert A. Winn Diversity in Clinical Trials Award Program, established by the Bristol Myers Squibb Foundation (BMSF), announced that Amgen has committed to contribute $8 million over the next four years. This contribution will enable the program to reach additional physicians and medical students.
0 Commentaires